AXGN [NASD]
AxoGen, Inc.
Index- P/E- EPS (ttm)-0.76 Insider Own4.90% Shs Outstand41.99M Perf Week8.89%
Market Cap530.55M Forward P/E- EPS next Y-0.45 Insider Trans-2.12% Shs Float40.30M Perf Month38.11%
Income-31.60M PEG- EPS next Q-0.12 Inst Own76.70% Short Float2.03% Perf Quarter44.29%
Sales128.20M P/S4.14 EPS this Y-10.00% Inst Trans-1.39% Short Ratio4.13 Perf Half Y49.94%
Book/sh2.42 P/B5.06 EPS next Y8.20% ROA-15.60% Target Price19.17 Perf Year-23.39%
Cash/sh1.34 P/C9.15 EPS next 5Y- ROE-29.20% 52W Range6.87 - 16.75 Perf YTD30.74%
Dividend- P/FCF- EPS past 5Y-6.90% ROI-16.20% 52W High-26.87% Beta0.72
Dividend %- Quick Ratio3.70 Sales past 5Y25.40% Gross Margin80.30% 52W Low78.31% ATR0.71
Employees428 Current Ratio4.50 Sales Q/Q2.70% Oper. Margin-24.40% RSI (14)66.86 Volatility7.94% 6.43%
OptionableYes Debt/Eq0.45 EPS Q/Q4.10% Profit Margin-24.70% Rel Volume2.93 Prev Close11.28
ShortableYes LT Debt/Eq0.45 EarningsAug 03 AMC Payout- Avg Volume198.34K Price12.25
Recom1.70 SMA2015.16% SMA5020.20% SMA20035.34% Volume580,842 Change8.60%
May-09-22Upgrade Canaccord Genuity Hold → Buy $10 → $15
Mar-11-22Resumed Cantor Fitzgerald Overweight $21
Oct-23-20Initiated Guggenheim Buy $24
Jun-16-20Resumed Cantor Fitzgerald Overweight $16
May-07-20Downgrade Canaccord Genuity Buy → Hold $12
Apr-02-20Downgrade BTIG Research Buy → Neutral
Aug-07-19Downgrade William Blair Outperform → Mkt Perform
Jul-12-19Initiated Canaccord Genuity Buy $32
Mar-02-18Reiterated Lake Street Buy $26 → $38
Jan-05-18Resumed Cantor Fitzgerald Overweight
Nov-30-17Initiated Jefferies Buy $35
Nov-21-17Reiterated Lake Street Buy $22 → $26
Jul-31-17Initiated Leerink Partners Outperform $22
Jun-30-17Initiated Cantor Fitzgerald Overweight $18
Mar-06-17Initiated ROTH Capital Buy $14.50
Nov-22-16Upgrade Lake Street Hold → Buy $9 → $11
Nov-07-16Reiterated Wedbush Outperform $10 → $12
Nov-03-16Downgrade Lake Street Buy → Hold $9
Aug-04-16Reiterated Wedbush Outperform $9 → $10
May-14-14Initiated Dawson James Buy $5
Sep-22-22 09:55AM
07:00AM
Aug-08-22 09:55AM
09:40AM
Aug-03-22 05:25PM
04:01PM Loading…
04:01PM
Jul-29-22 07:00AM
Jul-25-22 08:24AM
Jul-20-22 03:26PM
Jul-18-22 04:00PM
Jul-11-22 07:00AM
May-25-22 07:12AM
May-18-22 07:00AM
May-05-22 10:58AM
May-04-22 07:45PM
04:05PM Loading…
04:05PM
04:01PM
Apr-15-22 09:33AM
Apr-13-22 07:00AM
Mar-17-22 07:00AM
Feb-22-22 06:15PM
04:34PM
Feb-16-22 10:54AM
Feb-15-22 03:01PM
Feb-14-22 05:20AM
Feb-03-22 07:00AM
Feb-02-22 07:00AM
Jan-10-22 07:00AM
Jan-04-22 07:00AM
Dec-16-21 05:19AM
11:39AM Loading…
Dec-15-21 11:39AM
07:00AM
Dec-09-21 03:06PM
Nov-10-21 07:00AM
Nov-04-21 07:00AM
Nov-03-21 09:31PM
05:15PM
04:01PM
Oct-27-21 03:03PM
Oct-17-21 08:40AM
Oct-13-21 07:00AM
Sep-22-21 07:00AM
Sep-01-21 07:00AM
Aug-18-21 06:35AM
Aug-05-21 04:30AM
Aug-04-21 05:55PM
04:01PM
Jul-28-21 03:03PM
Jul-22-21 07:00AM
Jul-19-21 04:01PM
Jul-14-21 07:00AM
Jun-19-21 03:24AM
May-18-21 08:43AM
07:00AM
May-07-21 08:56AM
May-06-21 07:00AM
12:31AM
May-05-21 05:15PM
04:00PM
02:45PM
Apr-28-21 12:34PM
Apr-20-21 02:06AM
Apr-14-21 07:00AM
Mar-01-21 04:01PM
Feb-22-21 04:01PM
02:30PM
Feb-19-21 10:16AM
Feb-18-21 11:47PM
07:00AM
Feb-04-21 07:00AM
Feb-01-21 07:00AM
Jan-11-21 07:00AM
Jan-05-21 07:00AM
Jan-04-21 11:22PM
Dec-23-20 07:00AM
Dec-15-20 10:17PM
Nov-06-20 05:38AM
Nov-04-20 07:00AM
Oct-30-20 02:31PM
Oct-29-20 06:55PM
04:01PM
02:45PM
Oct-28-20 10:15AM
Oct-08-20 07:00AM
Sep-30-20 04:01PM
Sep-25-20 07:00AM
Sep-24-20 07:00AM
Aug-31-20 07:00AM
Aug-07-20 09:48AM
Aug-05-20 07:45PM
04:01PM
Jul-29-20 12:33PM
07:00AM
Jul-22-20 07:00AM
Jul-15-20 07:00AM
Jul-08-20 06:41PM
Jul-01-20 07:00AM
Jun-23-20 09:46AM
Jun-01-20 07:00AM
May-20-20 07:00AM
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Freitag Gregory GeneDirectorAug 10Sale9.708,88686,159365,583Aug 11 09:50 PM
Freitag Gregory GeneDirectorAug 08Sale10.3713,046135,287374,469Aug 08 05:49 PM
Freitag Gregory GeneDirectorAug 04Sale10.6424,000255,360387,515Aug 08 05:49 PM
Freitag Gregory GeneDirectorJul 25Option Exercise3.3883,000280,540441,811Jul 26 08:42 PM
Levine Alan MDirectorJun 01Option Exercise0.003,036011,800Jun 03 04:15 PM
Ottinger BradleyGeneral Counsel and CCOJun 01Option Exercise0.0015,500018,573Jun 03 04:11 PM
NEELS GUIDO JDirectorJun 01Option Exercise0.003,036051,800Jun 03 04:09 PM
Wendell Amy McBrideDirectorJun 01Option Exercise0.003,036035,133Jun 03 04:09 PM
Freitag Gregory GeneDirectorJun 01Option Exercise0.003,0360358,811Jun 03 04:06 PM
Gold Mark StephenDirectorJun 01Option Exercise0.003,0360305,475Jun 03 04:07 PM
Blackford Quentin S.DirectorMar 30Option Exercise0.003,036027,335Apr 01 04:55 PM
MARTINEZ MARIA D.Chief Human Resources OfficerMar 16Option Exercise0.0012,866019,522Mar 18 04:14 PM
Zaderej Karen L.CEOMar 16Option Exercise0.0025,9500966,333Mar 18 04:12 PM
Scopelianos AngeloChief R&D OfficerMar 16Option Exercise0.0011,000022,950Mar 18 04:11 PM
Sandberg EricChief Commercial OfficerMar 16Option Exercise0.006,000014,310Mar 18 04:10 PM
MARIANI PETER JEVP & Chief Financial OfficerMar 16Option Exercise0.0011,000037,353Mar 18 04:07 PM
Friedman Mark LouisVP Regulatory Affairs & PolicyMar 16Option Exercise0.006,000025,845Mar 18 04:06 PM
Donovan Michael PatrickVP OperationsMar 16Option Exercise0.006,000063,453Mar 18 04:05 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceMar 16Option Exercise0.006,000094,075Mar 18 04:03 PM
Billet IsabelleChief Strategy and BD OfficerMar 16Option Exercise0.008,500024,216Mar 18 04:01 PM
Donovan Michael PatrickVP OperationsFeb 22Option Exercise5.2115,00078,15057,453Feb 24 04:09 PM
Zaderej Karen L.CEODec 27Option Exercise0.004,4000927,429Dec 29 04:33 PM
Scopelianos AngeloChief R&D OfficerDec 27Option Exercise0.001,150011,270Dec 29 04:31 PM
MARTINEZ MARIA D.Chief Human Resources OfficerDec 27Option Exercise0.001,15006,017Dec 29 04:30 PM
MARIANI PETER JEVP & Chief Financial OfficerDec 27Option Exercise0.002,625024,794Dec 29 04:28 PM
Friedman Mark LouisVP Regulatory Affairs & PolicyDec 27Option Exercise0.001,150017,738Dec 29 04:23 PM
Donovan Michael PatrickVP OperationsDec 27Option Exercise0.001,150042,269Dec 29 04:21 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceDec 27Option Exercise0.00750087,436Dec 29 04:17 PM
Billet IsabelleChief Strategy and BD OfficerDec 27Option Exercise0.001,150014,510Dec 29 04:15 PM
MARIANI PETER JEVP & Chief Financial OfficerDec 20Option Exercise0.001,900022,926Dec 22 04:07 PM
Zaderej Karen L.CEODec 20Option Exercise0.003,1250924,272Dec 22 04:09 PM
Friedman Mark LouisVP Regulatory Affairs & PolicyDec 20Option Exercise0.00375016,683Dec 22 04:06 PM
Donovan Michael PatrickVP OperationsDec 20Option Exercise0.00375041,214Dec 22 04:04 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceDec 20Option Exercise0.00575086,830Dec 22 04:03 PM
DeVinney Erick WayneVP Peripheral Nerve ScienceDec 15Option Exercise3.6710,00036,70090,426Dec 17 04:02 PM
Zaderej Karen L.CEONov 24Option Exercise8.9552,375468,756921,147Nov 29 04:09 PM